Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin Sodium (Hipolabor) vs APP for VTE Prophylaxis
NCT00934167Phase 3Unknown
- Sponsor
- Azidus Laboratories Limited
- Start
- May 2010
- Primary completion
- Nov 2010
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of heparin in venous thromboembolism (VTE), sponsored by Azidus Laboratories Limited. Status: unknown.
02
Drugs
heparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00934167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00934167.